These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31940631)

  • 1. Report of Dialysis-Induced Hypophosphatemia Leading to Reversible Encephalopathy Prevented by Adding Phosphorus to the Dialysate.
    Koganti D; Sam R
    Blood Purif; 2020; 49(4):496-501. PubMed ID: 31940631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing/treating hypophosphatemia by adding phosphate to the dialysate.
    Sam R; Tang HL; Kjellstrand CM; Ing TS
    Int J Artif Organs; 2015 Dec; 38(12):671-2. PubMed ID: 26689145
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a phosphorus-enriched hemodialysate to prevent hypophosphatemia in a patient with renal failure-related pericarditis.
    Emelife-Obi C; Chow MT; Qamar-Rohail H; Leehey DJ; Gandhi VC; Ing TS
    Clin Nephrol; 1998 Aug; 50(2):131-3. PubMed ID: 9725787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: treatment with phosphorus-enriched hemodialysis.
    Chow MT; Lin HJ; Mitra EA; Singh S; Lee E; Leehey DJ; Ing TS
    Artif Organs; 1998 Oct; 22(10):905-7. PubMed ID: 9790091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.
    Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W
    Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raising plasma phosphorus levels by phosphorus-enriched, bicarbonate-containing dialysate in hemodialysis patients.
    Yu AW; Soundararajan R; Nawab ZM; Gandhi VC; Rahman MA; Popli S; Ing TS
    Artif Organs; 1992 Aug; 16(4):414-6. PubMed ID: 10078284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe lithium poisoning and dialysis-induced hypophosphatemia with phosphorus-enriched hemodialysis: a case report.
    Chebrolu SB; Yang HK; Hariman A; Tzamaloukas AH; Kjellstrand CM; Ing TS
    Chin Med J (Engl); 2005 Aug; 118(16):1405-8. PubMed ID: 16157041
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate.
    Gatchalian RA; Popli A; Ejaz AA; Leehey DJ; Kjellstrand CM; Ing TS
    Am J Kidney Dis; 2000 Dec; 36(6):1262-6. PubMed ID: 11096051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hypophosphatemia in nocturnal hemodialysis with phosphate-containing enema: a technical study.
    Su WS; Lekas P; Carlisle EJ; Cowin R; Bellamy J; Margetts PJ; Brimble KS; Clase CM; Gangji AS
    Hemodial Int; 2011 Apr; 15(2):219-25. PubMed ID: 21395970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a phosphorus-enriched dialysate in a hypercatabolic renal failure patient receiving intensive hemodialysis therapy.
    Zabaneh RI; Bhatt DM; Yu AW; Tiwari P; Lai CI; Leehey DJ; Ing TS
    Nephron; 1996; 72(4):696-8. PubMed ID: 8730447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorus dynamics during hemodialysis.
    Kjellstrand CM; Ing TS; Kjellstrand PT; Odar-Cederlof I; Lagg CR
    Hemodial Int; 2011 Apr; 15(2):226-33. PubMed ID: 21352467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.
    Garagarza C; Valente A; Caetano C; Oliveira T; Ponce P; Silva AP
    Int Urol Nephrol; 2017 Jul; 49(7):1243-1250. PubMed ID: 28265965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.
    Al-Hejaili F; Kortas C; Leitch R; Heidenheim AP; Clement L; Nesrallah G; Lindsay RM
    J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
    Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
    J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of Phosphorus by Hemodialysis.
    Daugirdas JT
    Semin Dial; 2015; 28(6):620-3. PubMed ID: 26358370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus-enriched hemodialysis during pregnancy: Two case reports.
    Hussain S; Savin V; Piering W; Tomasi J; Blumenthal S
    Hemodial Int; 2005 Apr; 9(2):147-52. PubMed ID: 16191063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged hypophosphatemia following parathyroidectomy in chronic hemodialysis patients.
    Shavit L; Lifschitz M; Slotki I
    Clin Nephrol; 2012 Nov; 78(5):399-405. PubMed ID: 23084333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of acetic acid for hydrochloric acid in the bicarbonate buffered dialysate.
    Fournier G; Potier J; Thébaud HE; Majdalani G; Ton-That H; Man NK
    Artif Organs; 1998 Jul; 22(7):608-13. PubMed ID: 9684700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.
    Broman M; Carlsson O; Friberg H; Wieslander A; Godaly G
    Acta Anaesthesiol Scand; 2011 Jan; 55(1):39-45. PubMed ID: 21039362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.